This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Drug-induced Cushing's syndrome
DRUGADVERS_CUSHI_SYNDR
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
41 |
4. Check minimum number of eventsNone |
41 |
5. Include endpointsNone |
41 |
6. Filter based on genotype QC (FinnGen only) |
41 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- C
- First used in FinnGen datafreeze
- DF5
Similar endpoints
↥List of similar endpoints to
Drug-induced Cushing's syndrome
based on the number of shared cases.
Similar with more cases:
- Cushing syndrome
- Exclusions for E4_PCOS_BROAD
- Disorders of other endocrine glands
- Exclusions for E4_PCOS_CONSORTIUM
- Endocrine, nutritional and metabolic diseases
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 190 | 121 | 67 |
| Only index persons | 173 | 112 | 61 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.00 | 0.00 | 0.00 |
| Only index persons | 0.00 | 0.00 | 0.00 |
| Median age at first event (years) | |||
| Whole population | 53.48 | 54.37 | 51.77 |
| Only index persons | 53.34 | 54.13 | 51.89 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 41 | 29 | 12 |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | 53.04 | 49.15 | 62.45 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
No data
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3018418) pH of Serum or Plasma
31
87
11.51
12.76
5.9
3.3
ph
7.4
7.4
—
7
14
(42870588) Differential panel, method unspecified - Blood
32
92
12.21
11.76
12.5
5.7
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
14
17
11.99
11.33
2.2
1.8
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
35
124
13.37
11.26
10.3
4.9
mmol/l
1.2
1.2
0.14
35
116
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
36
139
13.96
10.84
10.5
5.7
mmol/l
1.2
1.2
0.04
29
120
(3000991) Gas panel - Venous blood
13
17
10.73
9.88
8.9
2.8
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
12
14
11.70
9.87
2.8
1.4
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
18
36
8.13
9.67
2.5
2.5
%
18.6
23.9
0.75
18
30
(3014111) Lactate [Moles/volume] in Serum or Plasma
12
16
10.19
8.92
10.8
2.2
mmol/l
1.8
1.1
1.55
12
16
(3006315) Basophils [#/volume] in Blood
35
150
10.06
8.89
12.5
5.7
e9/l
0.0
0.0
0.64
30
133
(3001604) Monocytes [#/volume] in Blood
35
151
9.96
8.82
12.5
5.6
e9/l
0.7
0.6
1.88
30
133
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
10
11
11.70
8.44
1.0
1.1
g/l
0.3
0.3
—
10
11
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
10
12
10.70
7.93
1.0
1.1
g/l
1.4
1.3
—
10
12
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
10
12
10.70
7.93
9.2
4.4
%
0.8
0.7
—
10
12
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
11
16
9.03
7.56
2.2
2.1
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
10
13
9.85
7.46
3.5
3.2
mmol/l
21.8
24.6
—
10
13
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
10
13
9.85
7.46
8.9
4.2
%
1.0
2.2
—
10
13
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
29
113
6.35
7.42
5.5
2.7
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
18
46
6.19
7.38
1.9
1.3
titre
400.0
587.7
—
5
13
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
32
140
6.83
7.08
4.6
2.1
nmol/l
73.6
74.4
0.06
32
130
(3014576) Chloride [Moles/volume] in Serum or Plasma
14
29
6.81
7.05
9.0
4.3
mmol/l
105.6
103.7
0.67
14
29
(3014007) Fractional oxyhemoglobin in Arterial blood
10
14
9.12
7.03
9.2
4.4
%
94.6
91.4
—
10
14
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
15
34
6.38
6.91
2.6
1.5
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
11
18
7.99
6.82
2.1
1.1
u/ml
575.1
105.1
0.54
11
18
(3021589) Normoblasts [#/volume] in Blood
31
135
6.31
6.78
19.8
7.8
e9/l
0.0
0.0
0.49
25
109
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
28
113
5.66
6.67
2.3
1.9
pmol/l
86.9
96.4
0.52
15
58
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
15
36
5.99
6.47
2.6
1.5
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
21
69
5.19
6.35
10.1
4.2
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
11
21
6.79
5.89
3.6
2.5
kpa
5.4
5.6
0.25
11
21
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
17
50
5.10
5.79
3.0
1.8
—
—
—
0
0
(3012544) pH of Venous blood
11
22
6.47
5.62
3.6
2.6
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
9
9
12.38
5.33
2.4
1.0
g/l
0.0
0.0
—
9
9
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
9
9
12.38
5.33
2.4
1.0
g/l
0.1
1.2
—
9
9
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
9
9
12.38
5.33
2.4
1.0
g/l
0.0
0.0
—
9
9
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
9
9
12.38
5.33
2.4
1.0
g/l
0.0
0.0
—
9
9
(36304419) Bacteria [Presence] in Urine
23
91
4.48
5.32
5.8
2.5
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
23
92
4.42
5.22
5.8
2.5
e6/l
0.4
0.6
0.30
15
62
(3035350) Ketones [Presence] in Urine by Test strip
30
149
4.78
5.02
4.6
3.1
estimate
0.0
0.0
—
7
29
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
16
50
4.61
4.97
4.8
2.5
e6/l
5.9
2.4
—
7
25
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
20
75
4.25
4.89
2.2
1.6
mg/l
0.5
0.7
0.61
15
60
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
9
11
10.09
4.85
2.4
1.0
—
—
—
0
0
(3015736) pH of Urine
25
111
4.21
4.83
4.8
3.0
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
30
152
4.63
4.82
6.8
4.1
estimate
0.0
0.0
—
7
29
(3007164) IgA [Mass/volume] in Serum or Plasma
20
76
4.19
4.79
2.0
1.3
g/l
1.8
2.4
0.83
14
41
(40758558) Short blood count panel - Blood
22
90
4.12
4.75
14.1
7.5
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
16
52
4.41
4.70
3.0
2.3
ng/l
9.8
133.9
0.52
11
31
(3009261) Glucose [Presence] in Urine by Test strip
30
154
4.53
4.68
4.6
3.1
estimate
0.0
0.0
—
7
26
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
9
12
9.23
4.63
1.1
1.7
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
19
71
4.12
4.63
5.1
3.4
—
—
—
0
0
(3026782) Osmolality of Urine
17
60
4.13
4.45
3.6
2.3
mosm/kgh2o
602.7
508.2
0.55
12
47
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
17
61
4.05
4.34
4.6
2.2
e6/l
1.7
1.7
—
8
36
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
8
10
9.60
4.28
1.3
1.4
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
23
103
3.81
4.26
10.6
7.4
inr
1.0
1.2
0.68
11
26
(40768797) Stomach Pathology biopsy report
14
44
4.31
4.25
1.3
1.2
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
24
111
3.80
4.23
7.4
3.1
e6/l
69.6
58.6
0.06
16
77
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
7
7
11.71
4.18
1.4
1.3
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
6
5
13.70
3.89
1.0
1.4
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
22
102
3.50
3.76
6.0
2.5
e6/l
22.1
37.3
0.30
15
73
(3007853) Bacteria identified in Skin by Aerobe culture
12
37
4.17
3.68
2.3
1.5
—
—
—
0
0
(3022145) Colonoscopy Study observation
11
32
4.33
3.63
1.1
1.3
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
6
6
11.41
3.62
1.3
1.2
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
11
33
4.19
3.48
11.8
4.5
mmol/l
0.2
1.9
0.68
11
24
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
8
15
6.34
3.38
9.1
5.6
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
6
7
9.76
3.38
1.7
1.9
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
6
7
9.76
3.38
1.7
1.9
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
15
58
3.50
3.33
2.5
2.2
—
—
—
0
0
(3000492) Spirometry study
10
29
4.24
3.28
1.4
1.5
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
18
80
3.23
3.19
2.8
2.7
mg/l
10.9
55.7
—
10
44
(3037756) Immunofixation for Serum or Plasma
5
5
11.12
3.06
1.6
1.6
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
18
82
3.13
3.04
2.9
3.5
mg/mmol
1.4
7.9
—
9
48
(3021960) Folate [Moles/volume] in Serum or Plasma
15
63
3.18
2.88
1.9
1.5
nmol/l
16.9
20.0
0.54
15
55
(3020779) Urea [Moles/volume] in Serum or Plasma
9
24
4.50
2.88
8.3
7.9
mmol/l
9.0
7.0
—
9
24
(3024354) Oxygen [Partial pressure] in Venous blood
8
19
4.96
2.85
1.5
2.7
kpa
4.8
5.0
—
8
19
(3003327) Ova and parasites identified in Stool by Light microscopy
6
10
6.80
2.80
1.5
2.3
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
6
10
6.80
2.80
2.0
1.9
ug/l
0.6
0.4
—
6
10
(46235355) HIV 1 and 2 tests - Meaningful Use set
15
64
3.12
2.79
1.7
2.0
—
—
—
0
0
(4035726)
9
25
4.31
2.77
1.3
1.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
15
65
3.06
2.71
3.5
5.0
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
6
11
6.17
2.64
2.3
2.3
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
5
7
7.92
2.62
1.4
1.3
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
5
7
7.92
2.62
2.6
3.4
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
5
7
7.92
2.62
1.4
1.6
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
20
104
2.80
2.59
4.5
3.2
ng/l
12.8
23.6
2.10
13
60
(4010399)
9
27
3.97
2.58
1.4
1.5
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
5
9
6.14
2.28
1.6
1.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
5
9
6.14
2.28
2.4
2.0
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
5
9
6.14
2.28
1.2
1.4
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
5
9
6.14
2.28
3.0
1.8
%
80.2
104.0
—
5
9
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
7
19
4.21
2.26
5.9
3.9
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
6
14
4.82
2.24
1.2
2.7
g/l
121.7
131.4
—
6
14
(40761536) Microorganisms panel - Urine sediment
7
20
4.00
2.16
2.3
3.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
5
10
5.52
2.13
1.2
1.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
6
15
4.49
2.12
1.3
1.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
9
34
3.10
2.01
1.3
1.0
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
10
40
2.98
2.01
2.6
1.4
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
5
11
5.01
2.00
1.0
1.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
10
41
2.90
1.92
1.2
1.9
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
16
85
2.45
1.88
6.5
2.5
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
17
96
2.32
1.73
4.9
2.4
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
5
14
3.91
1.66
1.2
2.4
%
1.8
2.0
—
5
14
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
5
14
3.91
1.66
1.2
1.1
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
5
14
3.91
1.66
1.2
1.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
6
20
3.33
1.65
1.2
2.0
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
13
69
2.29
1.49
5.1
2.3
—
—
—
0
0
(3044889) 12 lead EKG panel
31
235
2.31
1.45
5.7
3.0
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
14
83
2.04
1.21
4.8
3.6
estimate
0.0
0.0
—
7
26
(3022217) INR in Platelet poor plasma by Coagulation assay
7
30
2.60
1.19
64.6
20.9
—
1.4
—
0
5
(3019060) Gas panel - Arterial blood
5
21
2.57
1.12
3.8
4.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
10
55
2.08
1.03
1.1
1.7
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
0
28
0.00
1.02
0.0
1.6
—
78.4
—
0
10
(3041096) Erythrocytes [Presence] in Urine by Automated
13
84
1.80
0.85
2.8
2.6
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
0
24
0.00
0.82
0.0
1.1
—
—
—
0
0
(40761535) Cells panel - Urine sediment
5
28
1.89
0.68
6.8
3.0
—
—
—
0
0
(3013512) EKG study
12
82
1.66
0.63
5.8
3.8
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
16
120
1.55
0.58
5.3
3.3
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
19
150
1.50
0.54
7.0
3.9
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
35
316
1.73
0.49
45.8
12.7
%
40.1
39.9
0.06
26
242
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
0
17
0.00
0.41
0.0
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
5
36
1.44
0.39
1.2
1.8
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
9
71
1.34
0.28
1.4
1.5
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.2
—
61.4
—
0
14
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
3.8
—
66.5
—
0
14
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
34
352
0.80
0.19
6.1
3.8
mmol/l
4.8
4.7
0.25
34
332
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
34
351
0.82
0.19
5.8
3.7
mmol/l
1.4
1.5
0.44
34
328
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
9
77
1.22
0.17
5.1
4.6
ug/l
1.4
2.1
—
9
71
(40768804) Tissue Pathology biopsy report
16
145
1.17
0.11
2.1
1.8
—
—
—
0
0
(3002256) Pathology report gross observation
5
45
1.13
0.10
1.4
1.2
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
35
340
1.20
0.08
5.3
3.3
mmol/l
2.0
1.2
2.05
35
316
(1761868) Lipid panel - Serum or Plasma
10
109
0.89
0.04
4.3
2.6
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
0.8
—
0
7
(4268621)
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
5
49
1.02
0.00
2.2
1.9
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
0
5
0.00
0.00
0.0
3.0
—
4.2
—
0
5
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
0
5
0.00
0.00
0.0
3.0
—
104.6
—
0
5
(3005033) Fetal Nuchal fold Thickness US
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
9
90
1.00
0.00
1.6
1.4
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
0
6
0.00
0.00
0.0
2.5
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
25
250
1.00
0.00
4.6
3.3
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
5
0.00
0.00
0.0
1.4
—
13.4
—
0
5
Mortality – FinRegistry
↥Association
Association between endpoint DRUGADVERS_CUSHI_SYNDR and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have DRUGADVERS_CUSHI_SYNDR.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: DRUGADVERS_CUSHI_SYNDR – Drug-induced Cushing's syndrome
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data